Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-07-06

Clinical Trial Update: Carbetocin Versus Ergometrine in the Management of Atonic Post Partum Haemorrhage (PPH) in Women Delivered Vaginally [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing carbetocin to ergometrine for the management of atonic postpartum hemorrhage in vaginal deliveries; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbetocin (carbetocin)
  • Ergometrine (ergometrine)

Snippet

Sponsor: Cairo University | Conditions: Post Partum Hemorrhage | Phase 3 | Status: UNKNOWN